Tuesday, September 26, 2017 5:39:16 PM
Senti,
Just this food for thought and your response, if you dont mind.
According to Westwickepartners a company should only file an 8K form if a shift of its financials of at least 10% is expected. Now NWBO has as far as I know (..), so far, ONLY filed 8K forms if there was indeed a shift in their financial situation: when they were selling shares, redeeming notes, converting debt and all that of a sort. NWBO has never (as far as I can tell) ever filed an 8K file on data soon to be announced and revealed. So NWBO's lawyer should have informed NWBO that if they expect the upcoming release of data to steer up (or down) the cash flow of the company in the near future, then they should file an 8K. The only thing IMO that is related closely to do so, is a working product (BLA, or AA or what not)...
Its the LAW! That simple. The cancelling of a Congress does not rock NWBO's cash flow for more than 10%, Bosch presentation of June 5 did not do so, more Bosch-like presentation will not bring in or down more then 10% cash flow.
If you dont believe me then you probably do not believe me either if I tell you that Amsterdam is not known particularly for its cuisine, Barcelona Bologne Paris etc are ;) IMO
Just this food for thought and your response, if you dont mind.
According to Westwickepartners a company should only file an 8K form if a shift of its financials of at least 10% is expected. Now NWBO has as far as I know (..), so far, ONLY filed 8K forms if there was indeed a shift in their financial situation: when they were selling shares, redeeming notes, converting debt and all that of a sort. NWBO has never (as far as I can tell) ever filed an 8K file on data soon to be announced and revealed. So NWBO's lawyer should have informed NWBO that if they expect the upcoming release of data to steer up (or down) the cash flow of the company in the near future, then they should file an 8K. The only thing IMO that is related closely to do so, is a working product (BLA, or AA or what not)...
Its the LAW! That simple. The cancelling of a Congress does not rock NWBO's cash flow for more than 10%, Bosch presentation of June 5 did not do so, more Bosch-like presentation will not bring in or down more then 10% cash flow.
If you dont believe me then you probably do not believe me either if I tell you that Amsterdam is not known particularly for its cuisine, Barcelona Bologne Paris etc are ;) IMO
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
